Amarin Corp Plc (AMRN)

[jessellivermore]

Some considerations...

I posted this information several years ago and several times..

If the Generics were to prevail in this trial it is important to understand Amarin will still be able to produce and sell Vascepa..In most every case Generic Strategy depends on undercutting the price of the brand..This is feasonable because most of the time brand drugs are marked up because the drug company justifies this because of the cost of developing the drug and getting it through the expensive FDA marketing process.

This strategy may not work in the case of Amarin..because as JT is fond of saying Vascepa is a volume drug and not a price drug. I is not obvious that the generics will be able to sell Vascepa at discount to what Amarin can..So far Amarin has a big jump on the generics in terms of the drug producers.. Right now Amarin is Walmart and the generics are the locals..

Also Generics will not be favored over brand Vascepa..The rule in drug In substitutions it is not the generic,,It is the cheapest alternative that is prescribed. I doubt the generics can beat Amarin's prices and remember producing pure EPA and the capsules is a very complex process with very few capable of doing this to FDA standards and it may be years before the generics can produce V acceptable to the FDA..

Som there will be some real problems for the generics and I am very confident they will have a lot of trouble even if the prevail in the patent case...

":>) JL